| BOT_Pharm_Ther_Summary-3-22-2013.pdf |
| BOT_Pharm_Ther_Summary-5-24-2013.pdf |
| BOT_Phar_Ther_Aug_2013_Min-1-31-2014.pdf |
| BOT_Phar_Ther_Nov_2013_Min-1-31-2014.pdf |
| BOT_Phar_Ther_Nov_Presentation-1-31-2014.pdf |
| BOT_Phase1_Disc_Rpt-1-31-2014.pdf |
| BOT_PhaseIDiscRptandRecommendations_11-19-15.pdf |
| BOT_Plan_Design-3-22-2013.pdf |
| BOT_Premium_Rates_2014-7-26-2013.pdf |
| BOT_Prem_Rate_2014-5-24-2013.pdf |
| BOT_Process_Discussion.pdf |
| BOT_Proposed_Revisions-9-5-2013.pdf |
| BOT_Provider_Pymt-1-31-2014.pdf |
| BOT_Q1_Forecast-11-22-2013.pdf |
| BOT_Q2_Update-3-22-2013.pdf |
| BOT_Q3_Acturarial_Forecast-7-26-2013.pdf |
| BOT_Q4_Forecast_Update-9-27-2013.pdf |
| BOT_Recommendation-3-22-2013.pdf |
| BOT_Reimbursement-1-31-2014.pdf |
| BOT_Revised_Bylaws-11-22-2013.pdf |
